BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3260705)

  • 1. Immunoglobulin M and G antibody response in rabbits after experimental Haemophilus ducreyi infection.
    Müller F; Müller KH
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):238-44. PubMed ID: 3260705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies.
    Roggen EL; Hoofd G; Van Dyck E; Piot P
    Sex Transm Dis; 1994; 21(1):36-42. PubMed ID: 8140487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an adsorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humans.
    Alfa MJ; Olson N; Degagne P; Slaney L; Plummer F; Namaara W; Ronald AR
    Sex Transm Dis; 1992; 19(6):309-14. PubMed ID: 1492255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi.
    Desjardins M; Thompson CE; Filion LG; Ndinya-Achola JO; Plummer FA; Ronald AR; Piot P; Cameron DW
    J Clin Microbiol; 1992 Aug; 30(8):2019-24. PubMed ID: 1500508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid.
    Desjardins M; Filion LG; Robertson S; Kobylinski L; Cameron DW
    Infect Immun; 1996 May; 64(5):1778-88. PubMed ID: 8613391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humoral immune response confers protection against Haemophilus ducreyi infection.
    Cole LE; Toffer KL; Fulcher RA; San Mateo LR; Orndorff PE; Kawula TH
    Infect Immun; 2003 Dec; 71(12):6971-7. PubMed ID: 14638786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease.
    Desjardins M; Filion LG; Robertson S; Cameron DW
    Infect Immun; 1995 May; 63(5):2012-20. PubMed ID: 7729916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.
    Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C
    Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an enzyme immunoassay to detect serum IgG antibodies to Haemophilus ducreyi.
    Museyi K; Van Dyck E; Vervoort T; Taylor D; Hoge C; Piot P
    J Infect Dis; 1988 May; 157(5):1039-43. PubMed ID: 3283255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid.
    Hansen EJ; Lumbley SR; Richardson JA; Purcell BK; Stevens MK; Cope LD; Datte J; Radolf JD
    J Immunol; 1994 Jan; 152(1):184-92. PubMed ID: 8254191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localisation and immunological properties of a 24-kDa surface protein of Haemophilus ducreyi.
    Frisk A; Roggen EL; Lagergård T
    J Med Microbiol; 1995 Sep; 43(3):192-200. PubMed ID: 7650727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.
    Purcell BK; Richardson JA; Radolf JD; Hansen EJ
    J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T
    Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dot-immunobinding and immunofluorescence assays to investigate clinically suspected cases of chancroid.
    Schalla WO; Sanders LL; Schmid GP; Tam MR; Morse SA
    J Infect Dis; 1986 May; 153(5):879-87. PubMed ID: 3517183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States.
    Chen CY; Mertz KJ; Spinola SM; Morse SA
    J Infect Dis; 1997 Jun; 175(6):1390-5. PubMed ID: 9180178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies reactive with all strains of Haemophilus ducreyi.
    Hansen EJ; Loftus TA
    Infect Immun; 1984 Apr; 44(1):196-8. PubMed ID: 6200440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies to Haemophilus ducreyi cytotoxin.
    Lagergård T; Purvén M
    Infect Immun; 1993 Apr; 61(4):1589-92. PubMed ID: 8454369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi.
    Alfa MJ; Olson N; Degagne P; Plummer F; Namaara W; Maclean I; Ronald AR
    J Infect Dis; 1993 May; 167(5):1206-10. PubMed ID: 8486955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of the immune response to Haemophilus ducreyi.
    Brown TJ; Ballard RC; Ison CA
    Microb Pathog; 1995 Jul; 19(1):31-8. PubMed ID: 8559038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.